Novo Nordisk A/S (NYSE:NVO ... A 4 billion yuan factory expansion in Tianjin was announced in March. While China’s national health insurance covers Ozempic for diabetes, Wegovy is unlikely ...

Novo Nordisk has a production site in Tianjin, China’s seventh-largest city, and employs more than 6,000 people in the country in manufacturing, research and commercial roles.

(Bloomberg) -- Novo Nordisk A/S will restrict initial sales ... In March, it announced a 4 billion yuan expansion of its factory in Tianjin, near the Chinese capital Beijing.

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market ...